Cardioonc Bot (@cardioonc_bot) 's Twitter Profile
Cardioonc Bot

@cardioonc_bot

unable to do my job since @TwitterDev just made getting #cardioonc information out to you $5,000. Cannot afford so bidding farewell.

ID: 1187846549751119874

calendar_today25-10-2019 21:41:08

35,35K Tweet

779 Followers

1 Following

Dr. Kevin Campbell, MD, FACC, MBA (@drkevincampbell) 's Twitter Profile Photo

.Mamas A. Mamas thank you for providing one of the most timely and important lectures on treating cardiovascular disease in the oncology patient today. One of the best lectures I’ve ever had the privilege of attending. #CardioOnc American College of Cardiology

International Cardio-Oncology Society (@icosociety) 's Twitter Profile Photo

"Kickstart #GCOS23 Day 1 with a Research Symposium and keynote by Valentin Fuster! Bonnie Ky & Carlo Tocchetti spearhead the 1st session. Fadi N Salloum navigates cardio toxicities prevention, then Dr. Kitsis discusses new mitochondrial therapies. Brace yourselves!"International Cardio-Oncology Society

"Kickstart #GCOS23 Day 1 with a Research Symposium and keynote by <a href="/FusterValentin/">Valentin Fuster</a>! Bonnie Ky &amp; Carlo Tocchetti spearhead the 1st session. <a href="/SALLOUMFN/">Fadi N Salloum</a> navigates cardio toxicities prevention, then Dr. Kitsis discusses new mitochondrial therapies. Brace yourselves!"<a href="/ICOSociety/">International Cardio-Oncology Society</a>
International Cardio-Oncology Society (@icosociety) 's Twitter Profile Photo

"Day 1, Session 2 of the Research Symposium highlights international collaboration in anthracycline cardiotoxicity. Explore two key initiatives: the RESILIENCE Project and the Leducq Network of Excellence-funded research. Dive in with us, and stay updated @ICOSSOCIETY!"#GCOS23

"Day 1, Session 2 of the Research Symposium highlights international collaboration in anthracycline cardiotoxicity. Explore two key initiatives: the RESILIENCE Project and the Leducq Network of Excellence-funded research. Dive in with us, and stay updated @ICOSSOCIETY!"#GCOS23
International Cardio-Oncology Society (@icosociety) 's Twitter Profile Photo

"Kindly participate in our voluntary survey on cardio-oncology education! Your input will help us identify gaps in training and develop better educational content for healthcare providers. Contribute to advancing cardio-oncology knowledge!" >> tinyurl.com/yewpc78f

"Kindly participate in our voluntary survey on cardio-oncology education! Your input will help us identify gaps in training and develop better educational content for healthcare providers. Contribute to advancing cardio-oncology knowledge!"

 &gt;&gt; tinyurl.com/yewpc78f
JACC Journals (@jaccjournals) 's Twitter Profile Photo

Remote ischemic conditioning does not exhibit cardioprotective effects in childhood cancer patients receiving anthracycline-based chemotherapy. bit.ly/3D9rvA8 #JACCCardioOnc #CardioOnc #Anthracycline #ayacsm #childhoodcancer #cvPed #CardioTwitter

Remote ischemic conditioning does not exhibit cardioprotective effects in childhood cancer patients receiving anthracycline-based chemotherapy. bit.ly/3D9rvA8

#JACCCardioOnc #CardioOnc #Anthracycline #ayacsm #childhoodcancer #cvPed #CardioTwitter
June Rhee (@junewrhee) 's Twitter Profile Photo

Calling all cardio-oncology enthusiasts for abstracts and registration! The first of its kind, translational #CardioOnc symposium by Dr. Andreas Beyer and team via American Physiological Society! physiology.org/professional-d…

ACC Media Center (@accmediacenter) 's Twitter Profile Photo

A #JACCCardioOnc study found that anticoagulants do not decrease the risk of ATEs for ambulatory cancer patients on systemic therapy. Read more in CancerTherapyAdvisor: bit.ly/3JUXqYO #cvCoag

Orly Leiva, MD (@leivaorly) 's Twitter Profile Photo

1/🔥 off the press. Had the pleasure of writing an editorial on an interesting paper characterizing PH phenotypes in patients with #mpnsm in ATS Blue Journal with Gaby Hobbs and Brenda García 🫁. Great 🫀🫁🩸 collaboration. #cardioonc #cardioheme. A short🧵 atsjournals.org/doi/abs/10.116…

Salim S. Hayek, MD (@salimhayek) 's Twitter Profile Photo

Hot off the press! Biomarkers are crucial in the diagnosis of ICI myotoxicity. This review goes through the most recent data and provides guidance on their use. #cardioonc U-M Health Frankel CVC DrJE-Salem Alexi Vasbinder, PhD, RN @anisi_a_ismail doi.org/10.1007/s11886…

DrJE-Salem (@drjesalem) 's Twitter Profile Photo

Another brick in the wall on the understanding of ICI mediated cardiovascular toxicities Javid Moslehi Wouter Meijers #cardiooncology #immunotherapy #vasculitis. CTLA-4 Pathway Is Instrumental in Giant Cell Arteritis | Circulation Research ahajournals.org/doi/10.1161/CI…

Hamid MERDJI, MD, PhD (@hamidmerdji) 's Twitter Profile Photo

4/ CS can be classified into 2 types in the new cardio-oncology syndrome classification (International Cardio-Oncology Society) Type 1 CS caused by cancer itself or indirectly through increased coronary risk, thromboembolic events, tamponade, or paraneoplastic syndrome. …rdiooncologyjournal.biomedcentral.com/articles/10.11…

International Cardio-Oncology Society (@icosociety) 's Twitter Profile Photo

"We're back on track with #GCOS23! Day 2 unfolds with two separate, yet equally insightful sessions. We kick-start with EHJ Editor-in-Chief, followed up by JACC CardioOncology addressing top cardio-oncology articles that will change practice & a roadmap for the cardio-oncology field!!"

"We're back on track with #GCOS23! Day 2 unfolds with two separate, yet equally insightful sessions. We kick-start with <a href="/ehj_ed/">EHJ Editor-in-Chief</a>, followed up by JACC CardioOncology addressing top cardio-oncology articles that will change practice &amp; a roadmap for the cardio-oncology field!!"
MayoPCCM (@mayopccm) 's Twitter Profile Photo

MayoPCCM faculty #DrTimothyAksamit and colleagues performed an #ArtificialIntelligence augmented propensity score looking into clinical, cost-effectiveness and ethical analysis of #cardiooncology cardiac arrests related mortality and disparities. #MedEd pubmed.ncbi.nlm.nih.gov/36013506/